| Date Filed | Type | Description |
| 02/03/2021 |
SC 13G
| Atlas Venture Fund VII L P reports a 6.3% stake in F-star Therapeutics, Inc. |
| 02/02/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2020 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 9.4% stake in ZAFGEN, INC. |
| 02/08/2019 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 9.4% stake in ZAFGEN, INC. |
| 07/02/2018 |
4
| Atlas Venture Fund VII L P (10% Owner) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Disposed of 1,126,546 shares
@ $0
Disposed of 234,321 shares
@ $0 |
|
| 02/09/2018 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 16.8% stake in ZAFGEN, INC. |
| 02/09/2018 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 6% stake in EGALET CORPORATION |
| 02/23/2017 |
SC 13D
| Atlas Venture Fund VII L P reports a 14.8% stake in MIRAGEN THERAPEUTICS, INC. |
| 02/13/2017 |
3
| Atlas Venture Fund VII L P (10% Owner) has filed a Form 3 on MIRAGEN THERAPEUTICS, INC. |
| 02/09/2017 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 16.9% stake in ZAFGEN, INC. |
| 02/09/2017 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 10.2% stake in EGALET CORPORATION |
| 02/12/2016 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 17% stake in ZAFGEN, INC. |
| 02/12/2016 |
SC 13G/A
| Atlas Venture Fund VII L P reports a 10.2% stake in EGALET CORPORATION |
| 03/26/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/12/2015 |
SC 13G
| Atlas Venture Fund VII L P reports a 14% stake in EGALET CORPORATION |
| 02/12/2015 |
SC 13G
| Atlas Venture Fund VII L P reports a 24.8% stake in ZAFGEN, INC. |
| 06/26/2014 |
4
| Atlas Venture Fund VII L P (10% Owner) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Converted 759,236 shares
@ $0
Converted 2,810,709 shares
@ $0
Converted 1,315,859 shares
@ $0
Converted 746,926 shares
@ $0
Converted 4,768,001 preferred shares
@ $0
Converted 17,651,253 preferred shares
@ $0
Converted 8,263,595 preferred shares
@ $0
Converted 4,690,696 preferred shares
@ $0 |
|
| 02/13/2014 |
SC 13G/A
| Atlas Venture Fund VII L P has filed a Schedule 13D for ARCA BIOPHARMA, INC. |
| 02/12/2014 |
4
| Atlas Venture Fund VII L P (10% Owner) has filed a Form 4 on Egalet Corp|
Txns:
| Converted 833,098 shares
@ $0
Converted 863,754 shares
@ $0
Converted 298,083 shares
@ $6, valued at
$1.8M
Converted 85,620 shares
@ $6, valued at
$513.7k
Bought 41,667 shares
@ $12, valued at
$500k
Converted 833,098 preferred shares
@ $0
Converted 863,754 preferred shares
@ $0
Exercised (in-or-at-the-money) 30,000 warrants
@ $0.001, valued at
$30
Converted options to buy
@ $6, valued at
$0 |
|
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 03/31/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
| 02/05/2009 |
3
| Atlas Venture Fund VII L P (10% Owner) has filed a Form 3 on ARCA biopharma, Inc. |